MedTrace Logo

Retrospective Observational Study DIANA Study

NCT01976793 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2014-11-13

No results posted yet for this study

Summary

This Non-Interventional Study (NIS) is intended to evaluate the duration of treatment with an initial antidepressant taken as monotherapy in patients in whom treatment was changed because of suboptimal response at physician's discretion. This will address unmet medical needs of patients with a depressive episode related to RDD (ICD-10, Version 2010), who have failed to respond adequately to initial treatment with an antidepressant and contribute to an understanding of the usual approaches that physicians adopt to monitor initial treatment efficacy in RDD (Recurrent Depressive Disorder). The study will also focus on second-line therapy in hard to treat patients, describing the different pharmacotherapeutic strategies.

Conditions

  • Major Depressive Episode

Sponsors & Collaborators

Principal Investigators

  • Alla Avedisova, Prof · Center of Social and Forensic Psychiatry, Moscow

  • Karin Otter, PhD · AstraZeneca Russia

  • Anatoly Smulevich, Prof · Scientific centef of Mental Health, Moscow

  • Galina Mazo, Prof · St Petersburg Scientific Psyconeurology institute

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01976793 on ClinicalTrials.gov